Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents

European Journal of Medicinal Chemistry

Volumn 142, Issue , 2017, Pages 459-485

  Dichiara, Maria ^a   Prezzavento, Orazio ^a   Marrazzo, Agostino ^a   Pittalà, Valeria ^a   Salerno, Loredana ^a   Rescifina, Antonio ^a   Amata, Emanuele ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cancer; Drug discovery; Non porphyrin photosensitizers; Photodynamic therapy; Reactive oxygen species; Singlet oxygen

Indexed keywords

ANTHRACENE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOTHIAZOLE DERIVATIVE; BENZYLIDENE DERIVATIVE; BORON DERIVATIVE; COUMARIN DERIVATIVE; CYCLOALKANONE; PHOTOSENSITIZING AGENT; RHODAMINE; REACTIVE OXYGEN METABOLITE;

A-549 CELL LINE; CELL VIABILITY; EC50; HEP-G2 CELL LINE; HK-1 CELL LINE (LUNG CARCINOMA); HL-60 CELL LINE; HSC-2 CELL LINE; HUMAN; IC50; JURKAT CELL LINE; K-562 CELL LINE; LOVO CELL LINE; MCF-7 CELL LINE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; NEOPLASM; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; DRUG DISCOVERY; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 85029724998     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2017.08.070     Document Type: Review

References (191)

1. Dolmans, D.E., Fukumura, D., Jain, R.K., Photodynamic therapy for cancer. Nat. Rev. Cancer 3 (2003), 380–387.
2. Szacilowski, K., Macyk, W., Drzewiecka-Matuszek, A., Brindell, M., Stochel, G., Bioinorganic photochemistry: frontiers and mechanisms. Chem. Rev. 105 (2005), 2647–2694.
3. Henderson, B.W., Dougherty, T.J., How does photodynamic therapy work?. Photochem. Photobiol. 55 (1992), 145–157.
4. Dysart, J.S., Patterson, M.S., Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 50 (2005), 2597–2616.
5. Bacellar, I.O., Tsubone, T.M., Pavani, C., Baptista, M.S., Photodynamic efficiency: from molecular photochemistry to cell death. Int. J. Mol. Sci. 16 (2015), 20523–20559.
6. Olivieri, M., Amata, E., Vinciguerra, S., Fiorito, J., Giurdanella, G., Drago, F., Caporarello, N., Prezzavento, O., Arena, E., Salerno, L., Rescifina, A., Lupo, G., Anfuso, C.D., Marrazzo, A., Antiangiogenic effect of (+/-)-Haloperidol metabolite II valproate ester [(+/-)-MRJF22] in human microvascular retinal endothelial cells. J. Med. Chem. 59 (2016), 9960–9966.
7. Marin-Ramos, N.I., Alonso, D., Ortega-Gutierrez, S., Ortega-Nogales, F.J., Balabasquer, M., Vazquez-Villa, H., Andradas, C., Blasco-Benito, S., Perez-Gomez, E., Canales, A., Jimenez-Barbero, J., Marquina, A., del Prado, J.M., Sanchez, C., Martin-Fontecha, M., Lopez-Rodriguez, M.L., New inhibitors of angiogenesis with antitumor activity in vivo. J. Med. Chem. 58 (2015), 3757–3766.
8. Lisnjak, I.O., Kutsenok, V., Polyschuk, L.Z., Gorobets, O.B., Gamaleia, N.E., Effect of photodynamic therapy on tumor angiogenesis and metastasis in mice bearing Lewis lung carcinoma. Exp. Oncol. 27 (2005), 333–335.
9. Soriano, J., Mora-Espi, I., Alea-Reyes, M.E., Perez-Garcia, L., Barrios, L., Ibanez, E., Nogues, C., Cell death mechanisms in tumoral and non-tumoral human cell lines triggered by photodynamic treatments: apoptosis, necrosis and parthanatos. Sci. Rep., 7, 2017, 41340.
10. Castano, A.P., Demidova, T.N., Hamblin, M.R., Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 1 (2004), 279–293.
11. Abrahamse, H., Hamblin, M.R., New photosensitizers for photodynamic therapy. Biochem. J. 473 (2016), 347–364.
12. Hearst, J.E., Isaacs, S.T., Kanne, D., Rapoport, H., Straub, K., The reaction of the psoralens with deoxyribonucleic acid. Q. Rev. Biophys. 17 (1984), 1–44.
13. Kitamura, N., Kohtani, S., Nakagaki, R., Molecular aspects of furocoumarin reactions: photophysics, photochemistry, photobiology, and structural analysis. J. Photochem. Photobiol. C 6 (2005), 168–185.
14. Zarebska, Z., Jarzabek-Chorzelska, M., Rzesa, G., Glinski, W., Pawinska, M., Chorzelski, T., Jablonska, S., Detection of DNA-psoralen photoadducts in situ. Photochem. Photobiol. 39 (1984), 307–312.
15. Allison, R.R., Sibata, C.H., Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagn. Photodyn. Ther. 7 (2010), 61–75.
16. Mang, T.S., Lasers and light sources for PDT: past, present and future. Photodiagn. Photodyn. Ther. 1 (2004), 43–48.
17. Xie, H.Y., Xie, Z.Y., Mousavi, M., Bendsoe, N., Brydegaard, M., Axelsson, J., Andersson-Engels, S., Design and validation of a fiber optic point probe instrument for therapy guidance and monitoring. J. Biomed. Opt., 19, 2014.
18. Bashkatov, A.N., Genina, E.A., Kochubey, V.I., Tuchin, V.V., Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J. Phys. D. Appl. Phys., 38, 2005, 2543.
19. Chen, H., Wang, G.D., Chuang, Y.J., Zhen, Z., Chen, X., Biddinger, P., Hao, Z., Liu, F., Shen, B., Pan, Z., Xie, J., Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment. Nano Lett. 15 (2015), 2249–2256.
20. Sitnik, T.M., Henderson, B.W., The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol. 67 (1998), 462–466.
21. Wang, H.F., Xu, Y.Y., Shi, J.P., Gao, X.H., Geng, L., Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol. Photoimmunol. Photomed. 31 (2015), 44–53.
22. Seshadri, M., Bellnier, D.A., Vaughan, L.A., Spernyak, J.A., Mazurchuk, R., Foster, T.H., Henderson, B.W., Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin. Cancer Res. 14 (2008), 2796–2805.
23. Svaasand, L.O., Photodynamic and photohyperthermic response of malignant tumors. Med. Phys. 12 (1985), 455–461.
24. Zimcik, P., Miletin, M., Kopecky, K., Musil, Z., Berka, P., Horakova, V., Kucerova, H., Zbytovska, J., Brault, D., Influence of aggregation on interaction of lipophilic, water-insoluble azaphthalocyanines with DOPC vesicles. Photochem. Photobiol. 83 (2007), 1497–1504.
25. Hamblin, M.R., Newman, E.L., On the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol. B 23 (1994), 3–8.
26. Stepniewski, M., Kepczynski, M., Jamroz, D., Nowakowska, M., Rissanen, S., Vattulainen, I., Rog, T., Interaction of hematoporphyrin with lipid membranes. J. Phys. Chem. B 116 (2012), 4889–4897.
27. Malik, Z., Amit, I., Rothmann, C., Subcellular localization of sulfonated tetraphenyl porphines in colon carcinoma cells by spectrally resolved imaging. Photochem. Photobiol. 65 (1997), 389–396.
28. Sailer, R., Strauss, W.S., Emmert, H., Stock, K., Steiner, R., Schneckenburger, H., Plasma membrane associated location of sulfonated meso-tetraphenylporphyrins of different hydrophilicity probed by total internal reflection fluorescence spectroscopy. Photochem. Photobiol. 71 (2000), 460–465.
29. Mojzisova, H., Bonneau, S., Vever-Bizet, C., Brault, D., Cellular uptake and subcellular distribution of chlorin e6 as functions of pH and interactions with membranes and lipoproteins. Biochim. Biophys. Acta 1768 (2007), 2748–2756.
30. Juarranz, A., Villanueva, A., Diaz, V., Canete, M., Photodynamic effects of the cationic porphyrin, mesotetra(4N-methylpyridyl)porphine, on microtubules of HeLa cells. J. Photochem. Photobiol. B 27 (1995), 47–53.
31. Rodriguez, M.E., Zhang, P., Azizuddin, K., Delos Santos, G.B., Chiu, S.M., Xue, L.Y., Berlin, J.C., Peng, X., Wu, H., Lam, M., Nieminen, A.L., Kenney, M.E., Oleinick, N.L., Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria. Photochem. Photobiol. 85 (2009), 1189–1200.
32. Boyle, R.W., Dolphin, D., Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64 (1996), 469–485.
33. Zheng, G., Potter, W.R., Camacho, S.H., Missert, J.R., Wang, G., Bellnier, D.A., Henderson, B.W., Rodgers, M.A., Dougherty, T.J., Pandey, R.K., Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1'-alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicity. J. Med. Chem. 44 (2001), 1540–1559.
34. Kim, Y.S., Song, R., Hyun Kim, D., Jun, M.J., Sohn, Y.S., Synthesis, biodistribution and antitumor activity of hematoporphyrin-platinum(II) conjugates. Bioorg. Med. Chem. 11 (2003), 1753–1760.
35. Marzorati, M., Bigler, P., Vermathen, M., Interactions between selected photosensitizers and model membranes: an NMR classification. Biochim. Biophys. Acta 1808 (2011), 1661–1672.
36. Cauchon, N., Tian, H., Langlois, R., La Madeleine, C., Martin, S., Ali, H., Hunting, D., van Lier, J.E., Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines. Bioconjug. Chem. 16 (2005), 80–89.
37. Henderson, B.W., Bellnier, D.A., Greco, W.R., Sharma, A., Pandey, R.K., Vaughan, L.A., Weishaupt, K.R., Dougherty, T.J., An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res. 57 (1997), 4000–4007.
38. Fischer, E., Varga, F., Hepatic storage and biliary excretion of rose bengal in the rat. Acta Physiol. Acad. Sci. Hung. 54 (1979), 89–94.
39. Sugita, N., Kawabata, K., Sasaki, K., Sakata, I., Umemura, S., Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation. Bioconjug. Chem. 18 (2007), 866–873.
40. Yang, W., Zou, Q., Zhou, Y., Zhao, Y., Huang, N., Gu, Y., Wu, F., Carboxylate modified benzylidene cyclopentanone dyes for one- and two-photon excited photodynamic therapy. J. Photochem. Photobiol. A Chem. 222 (2011), 228–235.
41. Zhao, Y., Wang, W., Wu, F., Zhou, Y., Huang, N., Gu, Y., Zou, Q., Yang, W., Polyethylene glycol-functionalized benzylidene cyclopentanone dyes for two-photon excited photodynamic therapy. Org. Biomol. Chem. 9 (2011), 4168–4175.
42. Spiller, W., Kliesch, H., Wohrle, D., Hackbarth, S., Roder, B., Schnurpfeil, G., Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions. J. Porphyr. Phthalocyanines 2 (1998), 145–158.
43. Amat-Guerri, F., Lempe, E., Lissi, E.A., Rodriguez, F.J., Trull, F.R., Water-soluble 1,3-diphenylisobenzofuran derivatives. Synthesis and evaluation as singlet molecular oxygen acceptors for biological systems. J. Photochem. Photobiol. A Chem. 93 (1996), 49–56.
44. Li, B.H., Lin, L.S., Lin, H.Y., Wilson, B.C., Photosensitized singlet oxygen generation and detection: recent advances and future perspectives in cancer photodynamic therapy. J. Biophot. 9 (2016), 1314–1325.
45. Josefsen, L.B., Boyle, R.W., Photodynamic therapy and the development of metal-based photosensitisers. Met.-Based Drugs, 2008, 2008, 276109.
46. Toratani, S., Tani, R., Kanda, T., Koizumi, K., Yoshioka, Y., Okamoto, T., Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Photodiagn. Photodyn. Ther. 14 (2016), 104–110.
47. Keeley, S.B., Pennathur, A., Gooding, W., Landreneau, R.J., Christie, N.A., Luketich, J., Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann. Surg. Oncol. 14 (2007), 2406–2410.
48. Ormond, A., Freeman, H., Dye sensitizers for photodynamic therapy. Materials, 6, 2013, 817.
49. O'Connor, A.E., Gallagher, W.M., Byrne, A.T., Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol. 85 (2009), 1053–1074.
50. Mitra, S., Foster, T.H., Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem. Photobiol. 81 (2005), 849–859.
51. Lorenz, K.J., Maier, H., Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan. HNO 56 (2008), 402–409.
52. Usuda, J., Kato, H., Okunaka, T., Furukawa, K., Tsutsui, H., Yamada, K., Suga, Y., Honda, H., Nagatsuka, Y., Ohira, T., Tsuboi, M., Hirano, T., Photodynamic therapy (PDT) for lung cancers. J. Thorac. Oncol. 1 (2006), 489–493.
53. Kang, H.K., Yun, J.H., Son, Y.M., Roh, J.Y., Lee, J.R., Photodynamic therapy for Bowen's disease of the vulva area. Ann. Dermatol. 26 (2014), 241–245.
54. Photodynamic therapy with LUZ11 in advanced head and neck cancer, in. https://ClinicalTrials.gov/show/NCT02070432.
55. Sibani, S.A., McCarron, P.A., Woolfson, A.D., Donnelly, R.F., Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin. Drug Deliv. 5 (2008), 1241–1254.
56. Sato, K., Nagaya, T., Choyke, P.L., Kobayashi, H., Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience. Theranostics 5 (2015), 698–709.
57. You, H., Yoon, H.E., Jeong, P.H., Ko, H., Yoon, J.H., Kim, Y.C., Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy. Bioorg. Med. Chem. 23 (2015), 1453–1462.
58. Hamblin, M.R., Newman, E.L., Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J. Photochem. Photobiol. B 26 (1994), 147–157.
59. Josefsen, L.B., Boyle, R.W., Photodynamic therapy: novel third-generation photosensitizers one step closer?. Br. J. Pharmacol. 154 (2008), 1–3.
60. Pereira, P.M., Korsak, B., Sarmento, B., Schneider, R.J., Fernandes, R., Tome, J.P., Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications. Org. Biomol. Chem. 13 (2015), 2518–2529.
61. Pereira, P.M., Carvalho, J.J., Silva, S., Cavaleiro, J.A., Schneider, R.J., Fernandes, R., Tome, J.P., Porphyrin conjugated with serum albumins and monoclonal antibodies boosts efficiency in targeted destruction of human bladder cancer cells. Org. Biomol. Chem. 12 (2014), 1804–1811.
62. Silva, S., Pereira, P.M., Silva, P., Paz, F.A., Faustino, M.A., Cavaleiro, J.A., Tome, J.P., Porphyrin and phthalocyanine glycodendritic conjugates: synthesis, photophysical and photochemical properties. Chem. Commun. (Camb.) 48 (2012), 3608–3610.
63. Pereira, P.M., Silva, S., Cavaleiro, J.A., Ribeiro, C.A., Tome, J.P., Fernandes, R., Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy. PLoS One, 9, 2014, e95529.
64. Shinoda, Y., Takahashi, T., Akimoto, J., Ichikawa, M., Yamazaki, H., Narumi, A., Yano, S., Fujiwara, Y., Comparative photodynamic therapy cytotoxicity of mannose-conjugated chlorin and talaporfin sodium in cultured human and rat cells. J. Toxicol. Sci. 42 (2017), 111–119.
65. Murakami, G., Nanashima, A., Nonaka, T., Tominaga, T., Wakata, K., Sumida, Y., Akashi, H., Okazaki, S., Kataoka, H., Nagayasu, T., Photodynamic therapy using novel glucose-conjugated chlorin increases apoptosis of cholangiocellular carcinoma in comparison with talaporfin sodium. Anticancer Res. 36 (2016), 4493–4501.
66. Balaz, M., Steinkruger, J.D., Ellestad, G.A., Berova, N., 5'-Porphyrin-oligonucleotide conjugates: neutral porphyrin-DNA interactions. Org. Lett. 7 (2005), 5613–5616.
67. Serra, V.V., Zamarron, A., Faustino, M.A., Cruz, M.C., Blazquez, A., Rodrigues, J.M., Neves, M.G., Cavaleiro, J.A., Juarranz, A., Sanz-Rodriguez, F., New porphyrin amino acid conjugates: synthesis and photodynamic effect in human epithelial cells. Bioorg. Med. Chem. 18 (2010), 6170–6178.
68. Frochot, C., Di Stasio, B., Vanderesse, R., Belgy, M.J., Dodeller, M., Guillemin, F., Viriot, M.L., Barberi-Heyob, M., Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity. Bioorg. Chem. 35 (2007), 205–220.
69. Stallivieri, A., Colombeau, L., Jetpisbayeva, G., Moussaron, A., Myrzakhmetov, B., Arnoux, P., Acherar, S., Vanderesse, R., Frochot, C., Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: synthesis and photophysical properties. Bioorg. Med. Chem. 25 (2017), 1–10.
70. Alemayehu, M., Wubshet, M., Mesfin, N., Gebayehu, A., Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. BMC Infect. Dis., 17, 2017, 152.
71. Brennan, N.K., Hall, J.P., Davies, S.R., Gollnick, S.O., Oseroff, A.R., Gibson, S.L., Hilf, R., Detty, M.R., In vitro photodynamic properties of chalcogenopyrylium analogues of the thiopyrylium antitumor agent AA1. J. Med. Chem. 45 (2002), 5123–5135.
72. Gorman, A., Killoran, J., O'Shea, C., Kenna, T., Gallagher, W.M., O'Shea, D.F., In vitro demonstration of the heavy-atom effect for photodynamic therapy. J. Am. Chem. Soc. 126 (2004), 10619–10631.
73. Yogo, T., Urano, Y., Ishitsuka, Y., Maniwa, F., Nagano, T., Highly efficient and photostable photosensitizer based on BODIPY chromophore. J. Am. Chem. Soc. 127 (2005), 12162–12163.
74. Zhao, J., Xu, K., Yang, W., Wang, Z., Zhong, F., The triplet excited state of Bodipy: formation, modulation and application. Chem. Soc. Rev. 44 (2015), 8904–8939.
75. Kamkaew, A., Lim, S.H., Lee, H.B., Kiew, L.V., Chung, L.Y., Burgess, K., BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 42 (2013), 77–88.
76. Lim, S.H., Thivierge, C., Nowak-Sliwinska, P., Han, J., van den Bergh, H., Wagnieres, G., Burgess, K., Lee, H.B., In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. J. Med. Chem. 53 (2010), 2865–2874.
77. Houghtaling, M.A., Perera, R., Owen, K.E., Wagner, S., Kuhn, R.J., Morrison, H., Photobiological properties of positively charged methylene violet analogs. Photochem. Photobiol. 71 (2000), 20–28.
78. Ohulchanskyy, T.Y., Donnelly, D.J., Detty, M.R., Prasad, P.N., Heteroatom substitution induced changes in excited-state photophysics and singlet oxygen generation in chalcogenoxanthylium dyes: effect of sulfur and selenium substitutions. J. Phys. Chem. B 108 (2004), 8668–8672.
79. Leonard, K.A., Nelen, M.I., Anderson, L.T., Gibson, S.L., Hilf, R., Detty, M.R., 2,4,6-triarylchalcogenopyrylium dyes related in structure to the antitumor agent AA1 as in vitro sensitizers for the photodynamic therapy of cancer. J. Med. Chem. 42 (1999), 3942–3952.
80. Pineiro, M., Gonsalves, A.M.D.R., Pereira, M.M., Formosinho, S.J., Arnaut, L.G., New halogenated phenylbacteriochlorins and their efficiency in singlet-oxygen sensitization. J. Phys. Chem. A 106 (2002), 3787–3795.
81. Zamarron, A., Lucena, S.R., Salazar, N., Sanz-Rodriguez, F., Jaen, P., Gilaberte, Y., Gonzalez, S., Juarranz, A., Isolation and characterization of PDT-resistant cancer cells. Photochem. Photobiol. Sci. 14 (2015), 1378–1389.
82. Casas, A., Di Venosa, G., Hasan, T., Al, B., Mechanisms of resistance to photodynamic therapy. Curr. Med. Chem. 18 (2011), 2486–2515.
83. Broekgaarden, M., Weijer, R., van Gulik, T.M., Hamblin, M.R., Heger, M., Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev. 34 (2015), 643–690.
84. Solar, P., Koval, J., Mikes, J., Kleban, J., Solarova, Z., Lazur, J., Hodorova, I., Fedorocko, P., Sytkowski, A.J., Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. Mol. Cancer Ther. 7 (2008), 2263–2271.
85. Kim, J., Lim, H., Kim, S., Cho, H., Kim, Y., Li, X., Choi, H., Kim, O., Effects of HSP27 downregulation on PDT resistance through PDT-induced autophagy in head and neck cancer cells. Oncol. Rep. 35 (2016), 2237–2245.
86. Lee, P.J., Jiang, B.H., Chin, B.Y., Iyer, N.V., Alam, J., Semenza, G.L., Choi, A.M., Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272 (1997), 5375–5381.
87. Weijer, R., Clavier, S., Zaal, E.A., Pijls, M.M., van Kooten, R.T., Vermaas, K., Leen, R., Jongejan, A., Moerland, P.D., van Kampen, A.H., van Kuilenburg, A.B., Berkers, C.R., Lemeer, S., Heger, M., Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy. Cell. Mol. Life Sci. 74 (2017), 1133–1151.
88. Yoon, J.H., Yoon, H.E., Kim, O., Kim, S.K., Ahn, S.G., Kang, K.W., The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers Surg. Med. 44 (2012), 76–86.
89. Lavrovsky, Y., Schwartzman, M.L., Levere, R.D., Kappas, A., Abraham, N.G., Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 5987–5991.
90. Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A., Dulak, J., Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell. Mol. Life Sci. 73 (2016), 3221–3247.
91. Abraham, N.G., Kappas, A., Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60 (2008), 79–127.
92. Atef, Y., El-Fayoumi, H.M., Abdel-Mottaleb, Y., Mahmoud, M.F., Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1. N. Schmied. Arch. Pharmacol., 390, 2017, 871, 10.1007/s00210-017-1389-9V.
93. Amata, E., Pittala, V., Marrazzo, A., Parenti, C., Prezzavento, O., Arena, E., Nabavi, S.M., Salerno, L., Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries. Clin. Sci. (Lond.) 131 (2017), 1701–1712.
94. Pittala, V., Vanella, L., Salerno, L., Romeo, G., Marrazzo, A., Di Giacomo, C., Sorrenti, V., Effects of polyphenolic derivatives on heme oxygenase-system in metabolic dysfunctions. Curr. Med. Chem., 24, 2017, 10.2174/0929867324666170616110748.
95. Yin, Y., Liu, Q., Wang, B., Chen, G., Xu, L., Zhou, H., Expression and function of heme oxygenase-1 in human gastric cancer. Exp. Biol. Med. (Maywood) 237 (2012), 362–371.
96. Noh, S.J., Bae, J.S., Jamiyandorj, U., Park, H.S., Kwon, K.S., Jung, S.H., Youn, H.J., Lee, H., Park, B.H., Chung, M.J., Moon, W.S., Kang, M.J., Jang, K.Y., Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer, 13, 2013, 516.
97. Degese, M.S., Mendizabal, J.E., Gandini, N.A., Gutkind, J.S., Molinolo, A., Hewitt, S.M., Curino, A.C., Coso, O.A., Facchinetti, M.M., Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77 (2012), 168–175.
98. Salerno, L., Pittala, V., Romeo, G., Modica, M.N., Siracusa, M.A., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Tibullo, D., Sorrenti, V., Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. Biorg. Med. Chem. 21 (2013), 5145–5153.
99. Gandini, N.A., Fermento, M.E., Salomon, D.G., Obiol, D.J., Andres, N.C., Zenklusen, J.C., Arevalo, J., Blasco, J., Lopez Romero, A., Facchinetti, M.M., Curino, A.C., Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma. Tumour Biol. 35 (2014), 2803–2815.
100. Tsai, J.R., Wang, H.M., Liu, P.L., Chen, Y.H., Yang, M.C., Chou, S.H., Cheng, Y.J., Yin, W.H., Hwang, J.J., Chong, I.W., High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell. Oncol. (Dordr.) 35 (2012), 461–471.
101. Na, H.K., Surh, Y.J., Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic. Biol. Med. 67 (2014), 353–365.
102. Grimm, S., Mvondo, D., Grune, T., Breusing, N., The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1. Biofactors 37 (2011), 17–24.
103. Nowis, D., Legat, M., Grzela, T., Niderla, J., Wilczek, E., Wilczynski, G.M., Glodkowska, E., Mrowka, P., Issat, T., Dulak, J., Jozkowicz, A., Was, H., Adamek, M., Wrzosek, A., Nazarewski, S., Makowski, M., Stoklosa, T., Jakobisiak, M., Golab, J., Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25 (2006), 3365–3374.
104. Frank, J., Lornejad-Schafer, M.R., Schoffl, H., Flaccus, A., Lambert, C., Biesalski, H.K., Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int. J. Oncol. 31 (2007), 1539–1545.
105. Miyake, M., Ishii, M., Kawashima, K., Kodama, T., Sugano, K., Fujimoto, K., Hirao, Y., siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines. Photochem. Photobiol. 85 (2009), 1020–1027.
106. Ohgari, Y., Miyata, Y., Miyagi, T., Gotoh, S., Ohta, T., Kataoka, T., Furuyama, K., Taketani, S., Roles of porphyrin and iron metabolisms in the delta-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells. Photochem. Photobiol. 87 (2011), 1138–1145.
107. Lin, P.H., Lan, W.M., Chau, L.Y., TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation. Oncogene 32 (2013), 2325–2334.
108. Pittala, V., Salerno, L., Romeo, G., Modica, M.N., Siracusa, M.A., A focus on heme Oxygenase-1 (HO-1) inhibitors. Curr. Med. Chem. 20 (2013), 3711–3732.
109. Salerno, L., Pittala, V., Romeo, G., Modica, M.N., Marrazzo, A., Siracusa, M.A., Sorrenti, V., Di Giacomo, C., Vanella, L., Parayath, N.N., Greish, K., Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines. Eur. J. Med. Chem. 96 (2015), 162–172.
110. Amata, E., Marrazzo, A., Dichiara, M., Modica, M.N., Salerno, L., Prezzavento, O., Nastasi, G., Rescifina, A., Romeo, G., Pittala, V., Heme oxygenase database (HemeOxDB) and QSAR analysis of isoform 1 inhibitors. Chem. Med. Chem., 2017, 10.1002/cmdc.201700321.
111. Martinez De Pinillos Bayona, A., Mroz, P., Thunshelle, C., Hamblin, M.R., Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers. Chem. Biol. Drug Des. 89 (2017), 192–206.
112. Idris, N.M., Jayakumar, M.K., Bansal, A., Zhang, Y., Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications. Chem. Soc. Rev. 44 (2015), 1449–1478.
113. Carvalho, C.M., Brocksom, T.J., de Oliveira, K.T., Tetrabenzoporphyrins: synthetic developments and applications. Chem. Soc. Rev. 42 (2013), 3302–3317.
114. Horne, T.K., Cronje, M.J., Mechanistics and photo-energetics of macrocycles and photodynamic therapy: an overview of aspects to consider for research. Chem. Biol. Drug Des. 89 (2017), 221–242.
115. Avirah, R.R., Jayaram, D.T., Adarsh, N., Ramaiah, D., Squaraine dyes in PDT: from basic design to in vivo demonstration. Org. Biomol. Chem. 10 (2012), 911–920.
116. Uzelac, L., Skalamera, D., Mlinaric-Majerski, K., Basaric, N., Kralj, M., Selective photocytotoxicity of anthrols on cancer stem-like cells: the effect of quinone methides or reactive oxygen species. Eur. J. Med. Chem. 137 (2017), 558–574.
117. Ryan, E.T., Xiang, T., Johnston, K.P., Fox, M.A., Absorption and fluorescence studies of acridine in subcritical and supercritical water. J. Phys. Chem. A 101 (1997), 1827–1835.
118. Yoshida, K., Kusuzaki, K., Matsubara, T., Matsumine, A., Kumamoto, T., Komada, Y., Naka, N., Uchida, A., Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange. Oncol. Rep. 13 (2005), 279–282.
119. D.M. O'Day, B.R. Jones, R. Poirier, S. Pilley, I. Chisholm, A. Steele, N.S.C. Rice, Proflavine photodynamic viral inactivation in herpes simplex keratitis, Am. J. Ophthalmol., 79 941–948.
120. Tomita, G., Absorption and fluorescence properties of some basic dyes complexing with nucleosides or nucleic acids. Z. für Naturforsch. B, 1968, 922.
121. Kusuzaki, K., Hosogi, S., Ashihara, E., Matsubara, T., Satonaka, H., Nakamura, T., Matsumine, A., Sudo, A., Uchida, A., Murata, H., Baldini, N., Fais, S., Marunaka, Y., Translational research of photodynamic therapy with acridine orange which targets cancer acidity. Curr. Pharm. Des. 18 (2012), 1414–1420.
122. Janovec, L., Kozurkova, M., Sabolova, D., Ungvarsky, J., Paulikova, H., Plsikova, J., Vantova, Z., Imrich, J., Cytotoxic 3,6-bis((imidazolidinone)imino)acridines: synthesis, DNA binding and molecular modeling. Bioorg. Med. Chem. 19 (2011), 1790–1801.
123. Cizekova, L., Grolmusova, A., Ipothova, Z., Barbierikova, Z., Brezova, V., Hunakova, L., Imrich, J., Janovec, L., Dovinova, I., Paulikova, H., Novel 3,6-bis(imidazolidine)acridines as effective photosensitizers for photodynamic therapy. Bioorg. Med. Chem. 22 (2014), 4684–4693.
124. Vantova, Z., Paulikova, H., Sabolova, D., Kozurkova, M., Suchanova, M., Janovec, L., Kristian, P., Imrich, J., Cytotoxic activity of acridin-3,6-diyl dithiourea hydrochlorides in human leukemia line HL-60 and resistant subline HL-60/ADR. Int. J. Biol. Macromol. 45 (2009), 174–180.
125. Cisarikova, A., Barbierikova, Z., Janovec, L., Imrich, J., Hunakova, L., Bacova, Z., Paulikova, H., Acridin-3,6-dialkyldithiourea hydrochlorides as new photosensitizers for photodynamic therapy of mouse leukemia cells. Bioorg. Med. Chem. 24 (2016), 2011–2022.
126. Kumar, R., Kaur, M., Kumari, M., Acridine: a versatile heterocyclic nucleus. Acta Pol. Pharm. 69 (2012), 3–9.
127. Amata, E., Bland, N.D., Hoyt, C.T., Settimo, L., Campbell, R.K., Pollastri, M.P., Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as trypanosoma brucei PDEB1 inhibitors. Bioorg. Med. Chem. Lett. 24 (2014), 4084–4089.
128. Amata, E., Bland, N.D., Campbell, R.K., Pollastri, M.P., Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1). Tetrahedron Lett. 56 (2015), 2832–2835.
129. Monteiro, J.S., de Oliveira, S.C., Pires Santos, G.M., Pires Sampaio, F.J., Pinheiro Soares, L.G., Pinheiro, A.L., Effectiveness of antimicrobial photodynamic therapy (AmPDT) on Staphylococcus aureus using phenothiazine compound with red laser. Lasers Med. Sci. 32 (2017), 29–34.
130. Garcia, V.G., Longo, M., Gualberto Junior, E.C., Bosco, A.F., Nagata, M.J., Ervolino, E., Theodoro, L.H., Effect of the concentration of phenothiazine photosensitizers in antimicrobial photodynamic therapy on bone loss and the immune inflammatory response of induced periodontitis in rats. J. Periodontal Res. 49 (2014), 584–594.
131. Fekrazad, R., Barghi, V.G., Mir, A.P.B., Shams-Ghahfarokhi, M., In vitro photodynamic inactivation of Candida albicans by phenothiazine dye (new methylene blue) and lndocyanine green (EmunDo (R)). Photodiagn. Photodyn. Ther. 12 (2015), 52–57.
132. Barbosa, A.F., Sangiorgi, B.B., Galdino, S.L., Barral-Netto, M., Pitta, I.R., Pinheiro, A.L., Photodynamic antimicrobial chemotherapy (PACT) using phenothiazine derivatives as photosensitizers against Leishmania braziliensis. Lasers Surg. Med. 44 (2012), 850–855.
133. Tardivo, J.P., Adami, F., Correa, J.A., Pinhal, M.A.S., Baptista, M.S., A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients. Photodiagn. Photodyn. Ther. 11 (2014), 342–350.
134. Graciano, T.B., Coutinho, T.S., Cressoni, C.B., Freitas, C.D., Pierre, M.B.R., Pereira, S.A.D., Shimano, M.M., Frange, R.C.D., Garcia, M.T.J., Using chitosan gels as a toluidine blue O delivery system for photodynamic therapy of buccal cancer: in vitro and in vivo studies. Photodiagn. Photodyn. Ther. 12 (2015), 98–107.
135. Mellish, K.J., Cox, R.D., Vernon, D.I., Griffiths, J., Brown, S.B., In vitro photodynamic activity of a series of methylene blue analogues. Photochem. Photobiol. 75 (2002), 392–397.
136. Hsieh, T.S., Wu, J.Y., Chang, C.C., Synthesis of a photostable near-infrared-absorbing photosensitizer for selective photodamage to cancer cells. Chem. East. 20 (2014), 9709–9715.
137. Muli, D.K., Rajaputra, P., You, Y., McGrath, D.V., Asymmetric ZnPc-rhodamine B conjugates for mitochondrial targeted photodynamic therapy. Bioorg. Med. Chem. Lett. 24 (2014), 4496–4500.
138. Pokorny, J., Pokorny, J., Kobilkova, J., Jandova, A., Vrba, J., Vrba, J., Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction. Prague Med. Rep. 115 (2014), 104–119.
139. Hill, J.E., Linder, M.K., Davies, K.S., Sawada, G.A., Morgan, J., Ohulchanskyy, T.Y., Detty, M.R., Selenorhodamine photosensitizers for photodynamic therapy of P-Glycoprotein-Expressing cancer cells. J. Med. Chem. 57 (2014), 8622–8634.
140. Kryman, M.W., Davies, K.S., Linder, M.K., Ohulchanskyy, T.Y., Detty, M.R., Selenorhodamine photosensitizers with the Texas-red core for photodynamic therapy of cancer cells. Bioorg. Med. Chem. 23 (2015), 4501–4507.
141. Davies, K.S., Linder, M.K., Kryman, M.W., Detty, M.R., Extended rhodamine photosensitizers for photodynamic therapy of cancer cells. Bioorg. Med. Chem. 24 (2016), 3908–3917.
142. Kryman, M.W., Schamerhorn, G.A., Hill, J.E., Calitree, B.D., Davies, K.S., Linder, M.K., Ohulchanskyy, T.Y., Detty, M.R., Synthesis and properties of heavy chalcogen analogues of the Texas reds and related rhodamines. Organometallics 33 (2014), 2628–2640.
143. Schinina, B., Martoran, A., Colabufo, N.A., Contino, M., Niso, M., Perrone, M.G., De Guidi, G., Catalfo, A., Rappazzo, G., Zuccarello, E., Prezzavento, O., Amata, E., Rescifina, A., Marrazzo, A., 4-Nitro-2,1,3-benzoxadiazole derivatives as potential fluorescent sigma receptor probes. RSC Adv. 5 (2015), 47108–47116.
144. Caruso, E., Gariboldi, M., Sangion, A., Gramatica, P., Banfi, S., Synthesis, photodynamic activity, and quantitative structure-activity relationship modelling of a series of BODIPYs. J. Photochem. Photobiol. B 167 (2017), 269–281.
145. Yang, Y., Guo, Q., Chen, H., Zhou, Z., Guo, Z., Shen, Z., Thienopyrrole-expanded BODIPY as a potential NIR photosensitizer for photodynamic therapy. Chem. Commun. (Camb.) 49 (2013), 3940–3942.
146. Andriani, G., Amata, E., Beatty, J., Clements, Z., Coffey, B.J., Courtemanche, G., Devine, W., Erath, J., Juda, C.E., Wawrzak, Z., Wood, J.T., Lepesheva, G.I., Rodriguez, A., Pollastri, M.P., Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth. J. Med. Chem. 56 (2013), 2556–2567.
147. Hu, W.P., Chen, Y.K., Liao, C.C., Yu, H.S., Tsai, Y.M., Huang, S.M., Tsai, F.Y., Shen, H.C., Chang, L.S., Wang, J.J., Synthesis, and biological evaluation of 2-(4-aminophenyl)benzothiazole derivatives as photosensitizing agents. Bioorg. Med. Chem. 18 (2010), 6197–6207.
148. Wu, C.S., Kuo, H.Y., Hu, W.P., Wang, J.J., Fang, A.H., Tien, L.Y., The ultraviolet A-activated photosensitizer 2-(4-aminophenyl)-7-methoxybenzothiazole suppresses proliferation and induces apoptosis of keloid fibroblasts: a potential adjunctive therapy for keloids. Clin. Exp. Dermatol. 40 (2015), 63–70.
149. Ronsisvalle, S., Arico, G., Cova, A.M., Blanco, P., Amata, E., Pappalardo, M., Pasquinucci, L., Spadaro, A., Ronsisvalle, N., Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist. Pharmazie 71 (2016), 146–151.
150. Corsaro, A., Pistarà, V., Chiacchio, M.A., Vittorino, E., Romeo, R., Synthesis of 4′-thionucleosides by 1,3-dipolar cycloadditions of the simplest thiocarbonyl ylide with alkenes bearing electron-withdrawing groups. Tetrahedron Lett. 48 (2007), 4915–4918.
151. Menichini, F., Tundis, R., Loizzo, M.R., Bonesi, M., Provenzano, E., de Cindio, B., Menichini, F., In vitro photo-induced cytotoxic activity of Citrus bergamia and C. medica L. cv. Diamante peel essential oils and identified active coumarins. Pharm. Biol. 48 (2010), 1059–1065.
152. Nakano, D., Ishitsuka, K., Matsuda, N., Kouguchi, A., Tsuchihashi, R., Okawa, M., Okabe, H., Tamura, K., Kinjo, J., Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (V): coumarins and alkaloids from Boenninghausenia japonica and Ruta graveolens. J. Nat. Med. 71 (2017), 170–180.
153. Zhou, Y., Zhao, W., Xie, G., Huang, M., Hu, M., Jiang, X., Zeng, D., Liu, J., Zhou, H., Chen, H., Wang, G.H., Zhang, X.K., Induction of Nur77-dependent apoptotic pathway by a coumarin derivative through activation of JNK and p38 MAPK. Carcinogenesis 35 (2014), 2660–2669.
154. Serrano-Perez, J.J., Merchan, M., Serrano-Andres, L., Photoreactivity of furocoumarins and DNA in PUVA therapy: formation of psoralen-thymine adducts. J. Phys. Chem. B 112 (2008), 14002–14010.
155. Oh, D.H., King, B.A., Boxer, S.G., Hanawalt, P.C., Spatially localized generation of nucleotide sequence-specific DNA damage. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 11271–11276.
156. Zou, Q., Fang, Y., Zhao, Y., Zhao, H., Wang, Y., Gu, Y., Wu, F., Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy. J. Med. Chem. 56 (2013), 5288–5294.
157. Barraja, P., Caracausi, L., Diana, P., Carbone, A., Montalbano, A., Cirrincione, G., Brun, P., Palu, G., Castagliuolo, I., Dall'acqua, F., Vedaldi, D., Salvador, A., Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage. Bioorg. Med. Chem. 18 (2010), 4830–4843.
158. Spano, V., Parrino, B., Carbone, A., Montalbano, A., Salvador, A., Brun, P., Vedaldi, D., Diana, P., Cirrincione, G., Barraja, P., Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer. Eur. J. Med. Chem. 102 (2015), 334–351.
159. Barraja, P., Diana, P., Montalbano, A., Carbone, A., Viola, G., Basso, G., Salvador, A., Vedaldi, D., Dall'Acqua, F., Cirrincione, G., Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents. Bioorg. Med. Chem. 19 (2011), 2326–2341.
160. Barraja, P., Caracausi, L., Diana, P., Montalbano, A., Carbone, A., Salvador, A., Brun, P., Castagliuolo, I., Tisi, S., Dall'Acqua, F., Vedaldi, D., Cirrincione, G., Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents. ChemMedChem 6 (2011), 1238–1248.
161. Dalla Via, L., Gia, O., Caffieri, S., Garcia-Argaez, A.N., Quezada, E., Uriarte, E., A novel tetrahydrobenzoangelicin with dark and photo biological activity. Bioorg. Med. Chem. 20 (2012), 3603–3608.
162. Spanò, V., Frasson, I., Giallombardo, D., Doria, F., Parrino, B., Carbone, A., Montalbano, A., Nadai, M., Diana, P., Cirrincione, G., Freccero, M., Richter, S.N., Barraja, P., Synthesis and antiproliferative mechanism of action of pyrrolo[3′,2′:6,7] cyclohepta[1,2-d]pyrimidin-2-amines as singlet oxygen photosensitizers. Eur. J. Med. Chem. 123 (2016), 447–461.
163. Spanò, V., Giallombardo, D., Cilibrasi, V., Parrino, B., Carbone, A., Montalbano, A., Frasson, I., Salvador, A., Richter, S.N., Doria, F., Freccero, M., Cascioferro, S., Diana, P., Cirrincione, G., Barraja, P., Pyrrolo[3′,2′:6,7]cyclohepta[1,2-b]pyridines with potent photo-antiproliferative activity. Eur. J. Med. Chem. 128 (2017), 300–318.
164. Jantová, S., Melušová, M., Pánik, M., Brezová, V., Barbieriková, Z., UVA-induced effects of 2,6-disubstituted 4-anilinoquinazolines on cancer cell lines. J. Photochem. Photobiol. B Biol. 154 (2016), 77–88.
165. Zou, Q., Zhao, H., Zhao, Y., Fang, Y., Chen, D., Ren, J., Wang, X., Wang, Y., Gu, Y., Wu, F., Effective two-photon excited photodynamic therapy of xenograft tumors sensitized by water-soluble bis(arylidene)cycloalkanone photosensitizers. J. Med. Chem. 58 (2015), 7949–7958.
166. Devine, W., Woodring, J.L., Swaminathan, U., Amata, E., Patel, G., Erath, J., Roncal, N.E., Lee, P.J., Leed, S.E., Rodriguez, A., Mensa-Wilmot, K., Sciotti, R.J., Pollastri, M.P., Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery. J. Med. Chem. 58 (2015), 5522–5537.
167. Catelani, G., D'Andrea, F., Guazzelli, L., Pistara, V., Toward the synthesis of fine chemicals from lactose: preparation of D-xylo and L-lyxo-aldohexos-5-ulose derivatives. Carbohydr. Res. 344 (2009), 717–724.
168. Pignatello, R., Panto, V., Basile, L., Impallomeni, G., Ballistreri, A., Pistara, V., Craparo, E.F., Puglisi, G., New amphiphilic conjugates of mono- and bis(carboxy)-PEG(2,000) polymers with lipoamino acids as surface modifiers of colloidal drug carriers. Macromol. Chem. Phys. 211 (2010), 1148–1156.
169. Quartarolo, A.D., Sicilia, E., Russo, N., On the potential use of squaraine derivatives as photosensitizers in photodynamic therapy: a TDDFT and RICC2 survey. J. Chem. Theory Comput. 5 (2009), 1849–1857.
170. Rapozzi, V., Beverina, L., Salice, P., Pagani, G.A., Camerin, M., Xodo, L.E., Photooxidation and Phototoxicity of pi-extended squaraines. J. Med. Chem. 53 (2010), 2188–2196.
171. Alex, S., Basheer, M.C., Arun, K.T., Ramaiah, D., Das, S., Aggregation properties of heavy atom substituted squaraine dyes: evidence for the formation of J-type dimer aggregates in aprotic solvents. J. Phys. Chem. A 111 (2007), 3226–3230.
172. Lee, J.J., White, A.G., Baumes, J.M., Smith, B.D., Microwave-assisted slipping synthesis of fluorescent squaraine rotaxane probe for bacterial imaging. Chem. Commun. (Camb.) 46 (2010), 1068–1069.
173. Gayathri Devi, D., Cibin, T.R., Ramaiah, D., Abraham, A., Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine: a novel candidate in photodynamic therapy for skin cancer models in vivo. J. Photochem. Photobiol. B 92 (2008), 153–159.
174. Shafeekh, K.M., Soumya, M.S., Rahim, M.A., Abraham, A., Das, S., Synthesis and characterization of near-infrared absorbing water soluble squaraines and study of their photodynamic effects in DLA live cells. Photochem. Photobiol. 90 (2014), 585–595.
175. Soumya, M.S., Shafeekh, K.M., Das, S., Abraham, A., Symmetrical diiodinated squaraine as an efficient photosensitizer for PDT applications: evidence from photodynamic and toxicological aspects. Chem. Biol. Interact. 222 (2014), 44–49.
176. Ramaiah, D., Joy, A., Chandrasekhar, N., Eldho, N.V., Das, S., George, M.V., Halogenated squaraine dyes as potential photochemotherapeutic agents. Synthesis and study of photophysical properties and quantum efficiencies of singlet oxygen generation*. Photochem. Photobiol. 65 (1997), 783–790.
177. Ramaiah, D., Eckert, I., Arun, K.T., Weidenfeller, L., Epe, B., Squaraine dyes for photodynamic therapy: study of their cytotoxicity and genotoxicity in bacteria and mammalian cells. Photochem. Photobiol. 76 (2002), 672–677.
178. Saneesh Babu, P.S., Manu, P.M., Dhanya, T.J., Tapas, P., Meera, R.N., Surendran, A., Aneesh, K.A., Vadakkancheril, S.J., Ramaiah, D., Nair, S.A., Pillai, M.R., Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine photodynamic therapy disrupts redox homeostasis and induce mitochondria-mediated apoptosis in human breast cancer cells. Sci. Rep., 7, 2017, 42126.
179. Serpe, L., Ellena, S., Barbero, N., Foglietta, F., Prandini, F., Gallo, M.P., Levi, R., Barolo, C., Canaparo, R., Visentin, S., Squaraines bearing halogenated moieties as anticancer photosensitizers: synthesis, characterization and biological evaluation. Eur. J. Med. Chem. 113 (2016), 187–197.
180. Romeo, R., Carnovale, C., Giofre, S.V., Chiacchio, M.A., Garozzo, A., Amata, E., Romeo, G., Chiacchio, U., C-5 ‘-Triazolyl-2’-oxa-3 ‘-aza-4’ a-carbanucleosides: synthesis and biological evaluation. Beilstein J. Org. Chem. 11 (2015), 328–334.
181. Delaey, E., van Laar, F., De Vos, D., Kamuhabwa, A., Jacobs, P., de Witte, P., A comparative study of the photosensitizing characteristics of some cyanine dyes. J. Photochem. Photobiol. B 55 (2000), 27–36.
182. Wainwright, M., Non-porphyrin photosensitizers in biomedicine. Chem. Soc. Rev. 25 (1996), 351–359.
183. Alander, J.T., Kaartinen, I., Laakso, A., Patila, T., Spillmann, T., Tuchin, V.V., Venermo, M., Valisuo, P., A review of indocyanine green fluorescent imaging in surgery. Int. J. Biomed. Imaging, 2012, 2012, 940585.
184. Ishizawa, T., Fukushima, N., Shibahara, J., Masuda, K., Tamura, S., Aoki, T., Hasegawa, K., Beck, Y., Fukayama, M., Kokudo, N., Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 115 (2009), 2491–2504.
185. Kulbacka, J., Pola, A., Mosiadz, D., Choromanska, A., Nowak, P., Kotulska, M., Majkowski, M., Hryniewicz-Jankowska, A., Purzyc, L., Saczko, J., Cyanines as efficient photosensitizers in photodynamic reaction: photophysical properties and in vitro photodynamic activity. Biochem. (Mosc.) 76 (2011), 473–479.
186. Kabatc, J., Paczkowski, J., The photophysical and photochemical properties of the oxacarbocyanine and thiacarbocyanine dyes. Dyes Pigm. 61 (2004), 1–16.
187. Jia, K., Wan, Y., Xia, A., Li, S., Gong, F., Yang, G., Characterization of photoinduced isomerization and intersystem crossing of the cyanine dye Cy3. J. Phys. Chem. A 111 (2007), 1593–1597.
188. Schaberle, F.A., Galembeck, S.E., Borissevitch, L.E., Computational study of steric and spectroscopic characteristics of bi-chromophoric cyanine dyes: comparison with experimental data. Spectrochim. Acta, Part A 72 (2009), 863–867.
189. Schaberle, F.A., Kuz'min, V.A., Borissevitch, I.E., Spectroscopic studies of the interaction of bichromophoric cyanine dyes with DNA. Effect of ionic strength. Biochim. Biophys. Acta, Gen. Subj. 1621 (2003), 183–191.
190. Murakami, L.S., Ferreira, L.P., Santos, J.S., da Silva, R.S., Nomizo, A., Kuz'min, V.A., Borissevitch, I.E., Photocytotoxicity of a cyanine dye with two chromophores toward melanoma and normal cells. Biochim. Biophys. Acta 1850 (2015), 1150–1157.
191. Atchison, J., Kamila, S., Nesbitt, H., Logan, K.A., Nicholas, D.M., Fowley, C., Davis, J., Callan, B., McHale, A.P., Callan, J.F., Iodinated cyanine dyes: a new class of sensitisers for use in NIR activated photodynamic therapy (PDT). Chem. Commun. (Camb.) 53 (2017), 2009–2012.